Breaking the Methamphetamine Supply Chain: Meeting Challenges at the Border: Hearing Before the U.S. Senate Committee on Finance, One Hundred Tenth Congress, First Session, September 18, 2007   [open pdf - 9MB]

From the opening statement of Max Baucus: "It is one year after enactment of the Combat Methamphetamine Epidemic Act. And there is evidence that we are making progress. The Combat Meth Act imposed limits on the sale of medicines containing ephedrine and pseudoephedrine. Those are the most common chemicals that can be converted into meth. And the Act required that purchasers provide identification and sign a sales log. Starting last year, retail sellers have been required to keep these products behind the counter or in a locked case. And retailers have had to register online. And partly as a result, last year, meth lab seizures declined 42 percent nationwide. The Combat Meth Act is disrupting supply. I am proud to have co-sponsored the law. But we must do more. Meth is still the number one law enforcement problem." Statements, letters, and materials submitted for the record include those of the following: Max Baucus, Charles Grassley, Thomas M. Siebel, Peter D. Wolfgram, Gary W. Kendell, Joseph T. Rannazzisi, Christy A. McCampbell, and Matthew C. Allen.

Report Number:
S. Hrg. 110-844
Public Domain
Retrieved From:
U.S. Senate Committee on Finance: http://finance.senate.gov/
Media Type:
Help with citations